Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T21:50:32.485Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:50:32.485Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 25,220,428
Total debt · period ending 2026-06-30: 1,763,590
Cash · period ending 2026-06-30: 31,944
TTM operating income · period ending 2026-06-30: -7,311,219

FMP input reference: 374a47b91f4df6a230cb26954d8d957a3b546ee3094b4b70ca7ed529159f4796

EV/EBITDA|EV/Sales|Operating Income|All Metrics

ABVC EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

EV/EBIT RATIO AVG TTM

N/A

EV/EBIT RATIO AVG 3Y

N/A

EV/EBIT RATIO AVG 5Y

N/A

EV/EBIT RATIO AVG 10Y

N/A

EV/EBIT RATIO AVG 15Y

N/A

EV/EBIT RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

ABVC Competitors' EV/EBIT Ratio

ABVC

ABVC BioPharma, Inc.

Current

Market Cap

$25.22M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSPR

InspireMD, Inc.

vs ABVC

Market Cap

$24.60M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATOS

Atossa Therapeutics, Inc.

vs ABVC

Market Cap

$24.44M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KYNB

Kyntra Bio, Inc.

vs ABVC

Market Cap

$24.13M

EV/EBIT Ratio

N/A

TTM Avg

104.01x

3Y Avg

104.01x

5Y Avg

104.01x

TVGN

Tevogen Bio Holdings Inc.

vs ABVC

Market Cap

$27.03M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TXMD

TherapeuticsMD, Inc.

vs ABVC

Market Cap

$23.38M

EV/EBIT Ratio

N/A

TTM Avg

0.54x

3Y Avg

0.52x

5Y Avg

0.52x

RNTX

Rein Therapeutics Inc.

vs ABVC

Market Cap

$23.06M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LONA

LeonaBio, Inc.

vs ABVC

Market Cap

$22.68M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATYR

aTyr Pharma, Inc.

vs ABVC

Market Cap

$27.79M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MCRB

Seres Therapeutics, Inc.

vs ABVC

Market Cap

$28.08M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
ABVC BioPharma, Inc. (ABVC)	$25.22M	N/A	N/A	N/A	N/A
InspireMD, Inc. (NSPR)vs ›	$24.60M	N/A	N/A	N/A	N/A
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.44M	N/A	N/A	N/A	N/A
Kyntra Bio, Inc. (KYNB)vs ›	$24.13M	N/A	104.01x	104.01x	104.01x
Tevogen Bio Holdings Inc. (TVGN)vs ›	$27.03M	N/A	N/A	N/A	N/A
TherapeuticsMD, Inc. (TXMD)vs ›	$23.38M	N/A	0.54x	0.52x	0.52x
Rein Therapeutics Inc. (RNTX)vs ›	$23.06M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$22.68M	N/A	N/A	N/A	N/A
aTyr Pharma, Inc. (ATYR)vs ›	$27.79M	N/A	N/A	N/A	N/A
Seres Therapeutics, Inc. (MCRB)vs ›	$28.08M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

ABVC EV/EBIT Ratio History

DATE	EV/EBIT RATIO
2005-11-14	9765.77x
2005-11-11	9765.77x
2005-11-10	9765.77x
2005-11-09	9765.77x
2005-11-08	9765.77x
2005-11-07	9765.77x
2005-11-04	9765.77x
2005-11-03	9765.77x
2005-11-02	9765.77x
2005-11-01	9765.77x
2005-10-31	9765.77x
2005-10-28	9765.77x
2005-10-27	9765.77x
2005-10-26	9765.77x
2005-10-25	9765.77x
2005-10-24	9765.77x
2005-10-21	9765.77x
2005-10-20	9765.77x
2005-10-19	9765.77x
2005-10-18	9765.77x
2005-10-17	9765.77x
2005-10-14	9765.77x
2005-10-13	9765.77x
2005-10-12	9765.77x
2005-10-11	9765.77x
2005-10-10	9765.77x
2005-10-07	9765.77x
2005-10-06	9765.77x
2005-10-05	6501.44x
2005-10-04	6501.44x
2005-10-03	6501.44x
2005-09-30	6501.44x
2005-09-29	6501.44x
2005-09-28	6501.44x
2005-09-27	6501.44x
2005-09-26	6501.44x
2005-09-23	6501.44x
2005-09-22	6501.44x
2005-09-21	6501.44x
2005-09-20	6501.44x
2005-09-19	6501.44x
2005-09-16	6501.44x
2005-09-15	6501.44x
2005-09-14	6501.44x
2005-09-13	6501.44x
2005-09-12	6501.44x
2005-09-09	6501.44x
2005-09-08	6501.44x
2005-09-07	6501.44x
2005-09-06	6501.44x
2005-09-02	6501.44x
2005-09-01	9765.77x
2005-08-31	9765.77x
2005-08-30	9765.77x
2005-08-29	9765.77x
2005-08-26	9765.77x
2005-08-25	9765.77x
2005-08-24	9765.77x
2005-08-23	9765.77x
2005-08-22	9765.77x
2005-08-19	9765.77x
2005-08-18	9765.77x
2005-08-17	9765.77x
2005-08-16	9765.77x
2005-08-15	9765.77x
2005-05-20	21759.61x
2005-05-19	21759.61x
2005-05-18	21759.61x
2005-05-17	21759.61x
2005-05-16	21759.61x
2005-05-13	21759.61x
2005-05-12	21759.61x
2005-05-11	21759.61x
2005-05-10	21759.61x
2005-05-09	21759.61x
2005-05-06	21759.61x
2005-05-05	21759.61x
2005-05-04	21759.61x
2005-05-03	21759.61x
2005-05-02	21759.61x
2005-04-29	21759.61x
2005-04-28	21759.61x
2005-04-27	21759.61x
2005-04-26	21759.61x
2005-04-25	10859.41x
2005-04-22	10859.41x
2005-04-21	10859.41x
2005-04-20	10859.41x
2005-04-19	10859.41x
2005-04-18	10859.41x
2005-04-15	10859.41x
2005-04-14	10859.41x
2005-04-13	10859.41x
2005-04-12	10859.41x
2005-04-11	10859.41x
2005-04-08	10859.41x
2005-04-07	10859.41x
2005-04-06	10859.41x
2005-04-05	10859.41x
2005-04-04	10859.41x
2005-04-01	10859.41x
2005-03-31	10859.41x

EV/EBIT Ratio: N/A

ABVC EV/EBIT Ratio Chart

ABVC EV/EBIT Ratio Metrics

ABVC Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

ABVC EV/EBIT Ratio History

Related Metrics